Second-Line Bosutinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: An 8-Year Update

Tim H. Brümmendorf, Carlo Gambacorti-Passerini, Dong-Wook Kim, Yeow Tee Goh, Iryna Dyagil, Katia B Pagnano, Árpád Bátai, Anna G Turkina, Jean M. Aguiar, Eric Leip and Jorge E. Cortes